Ultrahuman Raises $17.5M In Series B Investment
- ByAyushi Ray | August 17, 2021
Healthtech wearable Glucose tracker Ultrahuman raises $17.5M in Series B investment. This brings their total funding amount to $25M. The funding round saw participation from Alpha Wave Incubation (AWI), which is backed by DisruptAD and managed by Falcon Edge, Steadview Capital, Nexus Venture Partners, Blume Ventures, and Utsav Somani’s iSeed fund. “Biomarkers will change how the fitness and the healthcare industry works. By being able to continuously monitor their biomarkers like glucose, users can not only avoid chronic diseases but make lifestyle changes that help them improve their fitness levels for longevity and performance, ” said Ultrahuman Founder and CEO, Mohit Kumar.
This glucose tracking wearable helps people be conscious about their consumed diet and exercise. It was launched in 2021, but in just 2 months have garnered over 10000 users, and saw a 60 percent week-over-week growth. The funds raised will be used for geographical expansion and to improve their biomarker technology. The company stated it aims to help over a billion people in the world suffering from a metabolic health disorder. Ultrahuman is committed to making metabolic fitness accessible to millions of people globally. The funds raised will be used for geographical expansion and to improve their biomarker technology.
Follow Startup Story
Related Posts
